HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Zhou Selected Research

Emetine

11/2022Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.
1/2018Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Zhou Research Topics

Disease

207Neoplasms (Cancer)
12/2022 - 03/2002
46Inflammation (Inflammations)
05/2022 - 01/2010
44Infections
10/2022 - 07/2005
35Neoplasm Metastasis (Metastasis)
11/2022 - 01/2012
29Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2007
25Breast Neoplasms (Breast Cancer)
06/2022 - 05/2012
21Body Weight (Weight, Body)
06/2022 - 07/2005
20Fibrosis (Cirrhosis)
10/2022 - 07/2008
18Hypoxia (Hypoxemia)
07/2022 - 01/2009
17Hepatocellular Carcinoma (Hepatoma)
04/2022 - 02/2012
17Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 04/2010
16Lung Neoplasms (Lung Cancer)
05/2021 - 01/2011
15Stomach Neoplasms (Stomach Cancer)
11/2022 - 09/2010
15Schizophrenia (Dementia Praecox)
01/2022 - 12/2010
14Colonic Neoplasms (Colon Cancer)
12/2021 - 03/2002
14Carcinoma (Carcinomatosis)
12/2021 - 11/2011
12Alzheimer Disease (Alzheimer's Disease)
12/2022 - 10/2016
12Carcinogenesis
11/2022 - 01/2013
12COVID-19
05/2022 - 01/2020
12Wounds and Injuries (Trauma)
03/2021 - 11/2007
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 06/2010
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 06/2014
11Reperfusion Injury
12/2021 - 05/2012
10Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 09/2008
10Myocardial Infarction
10/2022 - 11/2007
10Osteoporosis
09/2022 - 06/2003
9Ischemic Stroke
06/2022 - 08/2013
9Hypertension (High Blood Pressure)
02/2022 - 05/2009
9Tuberculosis (Tuberculoses)
11/2021 - 10/2013
8Atherosclerosis
11/2022 - 01/2015
8Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 01/2014
8Stroke (Strokes)
06/2022 - 01/2012
8Diabetic Nephropathies (Diabetic Nephropathy)
05/2022 - 10/2010
8Triploidy
04/2022 - 09/2012
8Heart Failure
04/2022 - 06/2009
8Glioblastoma (Glioblastoma Multiforme)
03/2022 - 05/2016
8Obesity
02/2022 - 06/2009
8Insulin Resistance
02/2022 - 07/2011
8Melanoma (Melanoma, Malignant)
11/2021 - 07/2006
8Infarction (Infarctions)
06/2021 - 11/2007
8Leukemia
01/2021 - 05/2006
8Lymphatic Metastasis
01/2021 - 01/2012
7Cognitive Dysfunction
06/2022 - 01/2014
7Periodontitis
04/2022 - 01/2018
7Glioma (Gliomas)
03/2022 - 10/2010
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2011
7Ischemia
01/2022 - 11/2007
7Ulcer
01/2021 - 01/2010
7Liver Neoplasms (Liver Cancer)
01/2021 - 09/2010
7Hemorrhage
01/2021 - 05/2013
7Diabetes Mellitus
01/2018 - 10/2012
7Enteritis
04/2013 - 09/2008
6Liver Diseases (Liver Disease)
02/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

97Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2004
48Pharmaceutical PreparationsIBA
06/2022 - 03/2002
33Biomarkers (Surrogate Marker)IBA
12/2022 - 04/2012
26Messenger RNA (mRNA)IBA
04/2022 - 05/2005
23MicroRNAs (MicroRNA)IBA
04/2022 - 04/2012
21DNA (Deoxyribonucleic Acid)IBA
12/2022 - 08/2008
19CytokinesIBA
01/2022 - 08/2008
19Glucose (Dextrose)FDA LinkGeneric
12/2021 - 11/2013
18Biological ProductsIBA
01/2022 - 02/2006
16RNA (Ribonucleic Acid)IBA
10/2022 - 05/2013
16Peptides (Polypeptides)IBA
07/2022 - 10/2010
16Therapeutic UsesIBA
02/2022 - 03/2002
15Long Noncoding RNAIBA
11/2021 - 01/2017
14Doxorubicin (Adriamycin)FDA LinkGeneric
06/2022 - 06/2013
14LipidsIBA
02/2022 - 03/2013
11Transcription Factors (Transcription Factor)IBA
05/2022 - 01/2011
11LipopolysaccharidesIBA
05/2022 - 12/2011
11AntigensIBA
05/2021 - 01/2010
10IronIBA
06/2022 - 12/2002
10Small Interfering RNA (siRNA)IBA
04/2022 - 07/2014
10EnzymesIBA
01/2022 - 01/2014
10Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2020
10Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 07/2014
8VaccinesIBA
10/2022 - 07/2006
8LigandsIBA
01/2022 - 10/2018
8CateninsIBA
01/2022 - 01/2014
8Oxygen (Dioxygen)IBA
01/2021 - 05/2010
8Antiviral Agents (Antivirals)IBA
10/2020 - 07/2005
7oxidized low density lipoproteinIBA
11/2022 - 01/2011
7AcidsIBA
07/2022 - 01/2010
7CholesterolIBA
02/2022 - 07/2014
7NucleotidesIBA
01/2021 - 08/2008
7Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2010
7Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 - 05/2012
7Prostate-Specific Antigen (Semenogelase)IBA
04/2020 - 06/2007
7Uric Acid (Urate)IBA
11/2019 - 04/2012
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2011
6Adenosine Triphosphate (ATP)IBA
10/2022 - 11/2007
6Insulin (Novolin)FDA Link
06/2022 - 11/2013
6Tyrosine Kinase InhibitorsIBA
05/2022 - 08/2015
6Circular RNAIBA
04/2022 - 01/2021

Therapy/Procedure

105Therapeutics
12/2022 - 02/2005
24Drug Therapy (Chemotherapy)
01/2021 - 06/2007
12Radiotherapy
01/2021 - 06/2010
8Immunotherapy
10/2022 - 10/2010
8Brachytherapy
09/2021 - 06/2010
7Lasers (Laser)
01/2022 - 01/2011